Lijekovi 2

Deadline:11 May 2026, 08:00

Tender information
Скопски
Type
Contract
Procedure
Open procedure
Duration
22/05/2026 - 22/05/2027
lijekovi za liječenje multiple skleroze

1.Ocrelizumab 920 mg/23 ml (40 mg/ml)

1.Ocrelizumab ; otopina za injekciju - 920 mg/23 ml (40 mg/ml) ; 570 bočica

2.Fremanezumab 225 mg/1,5 ml

2.Fremanezumab ; otopina za injekciju - 225 mg/1,5 ml ; 900 napunjenu injekcijsku brizgalicu

3.Cladribine 10 mg

3.Cladribine ; tablet - 10 mg ; 1680 tableta

4.Natalizumab 150 mg/ml

4.Natalizumab ; otopina za injekciju - 150 mg/ml ; 1680 napunjena štrcaljka x 1 ml otopine

5.Ofatumumab 20 mg/0,4 ml

5.Ofatumumab ; otopina za injekciju - 20 mg/0,4 ml ; 600 napunjenu injekcijsku brizgalicu

Buyer
Sveučilišna klinika za neurologiju -Skoplje
buyer-email@mail.com
organization number

Documents

Document name
Upload date
File size
First document.pdf
1 Jan 1970, 00:001 Bytes
Second document.pdf
1 Jan 1970, 00:001 Bytes
Deadline passed
Important dates
10 Apr - Publication date
11 May - Deadline
Unlock Full Access with Mercell Bidding Business Plus
Start your free trial to explore exclusive features that help you win more tenders, faster:
AI-Powered Tender Insights
Buyer Contact Info
Key Tender Timelines

Already have an account?

Mercell Logo

Feel free to reach out!

Mercell is the leading European provider of e-tendering and procurement systems, and information between buyers and suppliers in the professional market.

We appreciate your input.

© Mercell Group 2026

Terms & Conditions and Privacy Notice

Mercell Group

  • Email: post@mercell.com
  • Phone: +47 21 01 88 00
  • Address: Askekroken 11, 0277 Oslo, Norway

Your privacy is important to us

We use cookies to improve your experience and evaluate each item on our site. By clicking further, you accept our use of cookies.